Insulin aspart, recombinant Subcutaneous and Naphazoline and pheniramine ophthalmic
Determining the interaction of Insulin aspart, recombinant Subcutaneous and Naphazoline and pheniramine ophthalmic and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Insulin aspart, Insulin Aspart
Generic Name: naphazoline / pheniramine ophthalmic
Brand name: Naphcon-A, Opcon-A, Visine-A, AK-Con-A, Ocuhist
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin aspart, recombinant Subcutaneous-Naphazoline Hydrochloride
- Insulin aspart, recombinant Subcutaneous-Naphazoline nasal
- Insulin aspart, recombinant Subcutaneous-Naphazoline ophthalmic
- Insulin aspart, recombinant Subcutaneous-Naphcon
- Insulin aspart, recombinant Subcutaneous-Naphcon Forte
- Insulin aspart, recombinant Subcutaneous-Naphcon-A
- Naphazoline and pheniramine ophthalmic-Insulin degludec
- Naphazoline and pheniramine ophthalmic-Insulin Degludec (U-100) Prefilled Pens
- Naphazoline and pheniramine ophthalmic-Insulin Degludec (U-100) Vials
- Naphazoline and pheniramine ophthalmic-Insulin Degludec (U-200) Prefilled Pens
- Naphazoline and pheniramine ophthalmic-Insulin degludec and liraglutide
- Naphazoline and pheniramine ophthalmic-Insulin degludec and liraglutide Subcutaneous